Roubaix Capital’s Ingevity NGVT Stock Holding History

Roubaix Capital’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-50,925	Closed	-$2.42M	–	56
2023 Q3	$2.42M	Buy	+50,925	New	+$2.78M	1.79%	31

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ICP

Inclusive Capital Partners San Francisco, California $26M AUM 22.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Roubaix Capital's NGVT Position: Q4 2023 in Review

Roubaix Capital sold out of Ingevity (NGVT) in Q4 2023, closing a stake of 50,925 shares — an estimated $2.42M sold.

Roubaix Capital first reported a position in NGVT in Q3 2023 and held it in 1 quarter. The position peaked at $2.42M in Q3 2023. 252 funds tracked by Wall St. Rank hold NGVT as of Q4 2023.

Roubaix Capital reported no remaining Ingevity position as of Q4 2023 after selling out during the quarter.
Roubaix Capital sold 50,925 Ingevity shares in Q4 2023, an estimated $2.42M.
Roubaix Capital first reported a position in Ingevity in Q3 2023 and held it in 1 quarter.
Roubaix Capital's Ingevity position peaked at $2.42M in Q3 2023.
252 funds tracked by Wall St. Rank held Ingevity as of Q4 2023.

Based on Roubaix Capital's 13F filing for Q4 2023, filed 8 Feb 2024.